Titan Biotech Limited (BOM:524717)

Market Cap	3.83B
Revenue (ttm)	1.56B
Net Income (ttm)	215.32M
Shares Out	8.26M
EPS (ttm)	26.06
PE Ratio	17.79
Forward PE	n/a
Dividend	2.00 (0.43%)
Ex-Dividend Date	Sep 23, 2024

Volume	4,704
Average Volume	10,130
Open	456.00
Previous Close	453.55
Day's Range	447.20 - 460.95
52-Week Range	373.65 - 1,017.85
Beta	0.35
RSI	66.44
Earnings Date	Aug 12, 2025

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1992
• Employees: 449
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524717

Financial Performance

In 2024, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.